10 | Pharmaceutical PreparationsIBA
01/2022
-
10/2002 |
6 | DNA (Deoxyribonucleic Acid)IBA
01/2019
-
09/2004 |
6 | Proteins (Proteins, Gene)FDA Link
01/2019
-
04/2008 |
6 | Biomarkers (Surrogate Marker)IBA
01/2019
-
01/2012 |
4 | Phosphotransferases (Kinase)IBA
01/2020
-
01/2013 |
4 | Biological ProductsIBA
01/2019
-
06/2002 |
4 | 4- (3- (2- nitro- 1- imidazolyl)- propylamino)- 7- chloroquinoline hydrochlorideIBA
07/2007
-
09/2002 |
4 | Cytotoxins (Cytolysins)IBA
07/2007
-
09/2002 |
3 | Paclitaxel (Taxol)FDA LinkGeneric
01/2020
-
12/2002 |
3 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011
-
06/2003 |
2 | Transcription Factors (Transcription Factor)IBA
01/2018
-
07/2011 |
2 | AntibodiesIBA
01/2018
-
06/2003 |
2 | RNA (Ribonucleic Acid)IBA
10/2013
-
02/2009 |
2 | AgarIBA
01/2013
-
07/2011 |
2 | artemisinin (artemisinine)IBA
09/2009
-
01/2009 |
2 | SuspensionsIBA
04/2008
-
04/2007 |
2 | NSC 680410IBA
06/2007
-
03/2005 |
2 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2007
-
09/2002 |
2 | 1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA
09/2004
-
09/2004 |
2 | Cisplatin (Platino)FDA LinkGeneric
09/2004
-
07/2004 |
2 | Tirapazamine (SR 4233)IBA
12/2002
-
09/2002 |
1 | Anti-Obesity Agents (Antiobesity Drugs)IBA
01/2022 |
1 | Temozolomide (Temodar)FDA LinkGeneric
10/2021 |
1 | AZD8186IBA
01/2021 |
1 | AZD 6244IBA
01/2021 |
1 | MK 2206IBA
01/2021 |
1 | CytidineIBA
01/2021 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 |
1 | Cadherins (E-Cadherin)IBA
01/2020 |
1 | VimentinIBA
01/2020 |
1 | TubulinIBA
01/2020 |
1 | talazoparibIBA
01/2020 |
1 | Tyrosine Kinase InhibitorsIBA
01/2020 |
1 | pazopanibFDA Link
01/2020 |
1 | nilotinibFDA Link
01/2020 |
1 | silvestrolIBA
01/2020 |
1 | CaspasesIBA
01/2020 |
1 | rocaglamideIBA
01/2020 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 |
1 | Insulin (Novolin)FDA Link
01/2020 |
1 | CateninsIBA
01/2020 |
1 | Eukaryotic Initiation Factor-4F (EIF4F)IBA
01/2020 |
1 | Focal Adhesion Protein-Tyrosine KinasesIBA
01/2018 |
1 | EMD1214063IBA
01/2018 |
1 | tepotinibIBA
01/2018 |
1 | cabozantinibIBA
01/2018 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2018 |
1 | ARQ 197IBA
01/2018 |
1 | defactinibIBA
01/2018 |
1 | GSK 1363089IBA
01/2018 |
1 | Indicators and Reagents (Reagents)IBA
01/2018 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017 |
1 | birinapantIBA
02/2016 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
02/2016 |
1 | CrizotinibIBA
01/2016 |
1 | 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
01/2016 |
1 | Complementary DNA (cDNA)IBA
05/2014 |
1 | adavosertibIBA
05/2014 |
1 | tyrosine receptor (receptor, tyrosine)IBA
05/2014 |
1 | Oxyphenisatin Acetate (Oxyphenisatine)IBA
10/2013 |
1 | Type I Tumor Necrosis Factor ReceptorsIBA
10/2013 |
1 | 2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA
08/2013 |
1 | decanoic acid (capric acid)IBA
08/2013 |
1 | Sulfates (Sulfates, Inorganic)IBA
08/2013 |
1 | estradiol 17 beta-cypionate (Depo-estradiol)FDA LinkGeneric
08/2013 |
1 | Fatty Acids (Saturated Fatty Acids)IBA
08/2013 |
1 | GlucuronidesIBA
08/2013 |
1 | Coumaric AcidsIBA
08/2013 |
1 | AcidsIBA
08/2013 |
1 | GTP Phosphohydrolases (GTPases)IBA
01/2013 |
1 | SC1 compoundIBA
01/2013 |
1 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
07/2012 |
1 | Vincristine (Oncovin)FDA LinkGeneric
01/2012 |
1 | trans-sodium crocetinate (crocetin)IBA
01/2012 |
1 | ProteomeIBA
01/2012 |
1 | Aldehyde DehydrogenaseIBA
01/2012 |
1 | Telomerase (Telomerase Reverse Transcriptase)IBA
01/2012 |
1 | NestinIBA
01/2012 |